: North American sales have shown significant contraction (down ~10%) due to weak demand.

: Positive, with high-impact open-market purchases by multiple insiders in the past year.

: Average 12-month price targets range from $5.61 to $6.91 , representing a modest potential upside of 3% to 8% from current levels (~$6.40). Contrarian "Buy" Signals :